Recombinant multi-species AKT2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AKT2 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains, which is involved in signaling pathways. The gene serves as an oncogene in the tumorigenesis of cancer cells For example, its overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins, and has also been implicated in insulin signaling. [provided by RefSeq, Nov 2019]
The Alternative Names of target: 2410016A19Rik,AKT2,Akt2,HIHGHH,PKB,PKBB,PKBBETA,PKBbeta,PRKBB,Protein kinase Akt-2,Protein kinase B beta (PKB beta),RAC protein kinase beta (RAC-PK-beta),RAC-BETA,RAC-beta serine/threonine-protein kinase

Target products collectionGo to AKT2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T94621-Ag-1/ GM-Tg-hg-T94621-Ag-2 Human AKT2 protein Human
GM-Tg-rg-T94621-Ag-1/ GM-Tg-rg-T94621-Ag-2 Rat AKT2 protein Rat
GM-Tg-mg-T94621-Ag-1/ GM-Tg-mg-T94621-Ag-2 Mouse AKT2 protein Mouse
GM-Tg-cynog-T94621-Ag-1/ GM-Tg-cynog-T94621-Ag-2 Cynomolgus/Rhesus macaque AKT2 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T94621-Ag-1/ GM-Tg-felg-T94621-Ag-2 Feline AKT2 protein Feline
GM-Tg-cang-T94621-Ag-1/ GM-Tg-cang-T94621-Ag-2 Canine AKT2 protein Canine
GM-Tg-bovg-T94621-Ag-1/ GM-Tg-bovg-T94621-Ag-2 Bovine AKT2 protein Bovine
GM-Tg-equg-T94621-Ag-1/ GM-Tg-equg-T94621-Ag-2 Equine AKT2 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T94621-Ag-1/ GM-Tg-hg-T94621-Ag-2; GM-Tg-rg-T94621-Ag-1/ GM-Tg-rg-T94621-Ag-2;
GM-Tg-mg-T94621-Ag-1/ GM-Tg-mg-T94621-Ag-2; GM-Tg-cynog-T94621-Ag-1/ GM-Tg-cynog-T94621-Ag-2;
GM-Tg-felg-T94621-Ag-1/ GM-Tg-felg-T94621-Ag-2; GM-Tg-cang-T94621-Ag-1/ GM-Tg-cang-T94621-Ag-2;
GM-Tg-bovg-T94621-Ag-1/ GM-Tg-bovg-T94621-Ag-2; GM-Tg-equg-T94621-Ag-1/ GM-Tg-equg-T94621-Ag-2
Products Name AKT2 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name AKT2
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine AKT2 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.